TG Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.About TGTX
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.
TGTX Key Statistics
Stock Snapshot
With a market cap of 4.78B, TG Therapeutics(TGTX) trades at $29.94. The stock has a price-to-earnings ratio of 9.98.
On 2026-01-14, TG Therapeutics(TGTX) stock moved within a range of $28.45 to $33.24. With shares now at $29.94, the stock is trading +5.2% above its intraday low and -9.9% below the session's peak.
Trading volume for TG Therapeutics(TGTX) stock has reached 7.04M, versus its average volume of 2.36M.
The stock's 52-week range extends from a low of $25.28 to a high of $46.48.
The stock's 52-week range extends from a low of $25.28 to a high of $46.48.
TGTX News
U.S. stocks were lower, with the Nasdaq Composite falling more than 200 points on Wednesday. Shares of TG Therapeutics Inc (NASDAQ:TGTX) rose sharply during We...
TG Therapeutics, Inc. (NASDAQ:TGTX) shares are trading higher after the company reported preliminary fiscal-year 2025 total global revenue results on Tuesday af...
TG Therapeutics, Inc. (NASDAQ:TGTX) shares climbed in Tuesday’s extended trading after the company released its preliminary fourth quarter revenue estimates and...
